Author: admin
Webinar Presented by Integral Molecular and IPWatchdog – Resurrecting Antibody Genus Protection: Allowed Claims Through CDR-Scanning
Thursday, March 5, 2026 12 pm ET View the recording New antibody patenting strategies, such as structure-based genus and means plus function claims, are […]
10x Faster Virus Neutralization Testing With Launch of Integral Molecular’s Ready Reporter Virus™ Kit
Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development Philadelphia – Integral Molecular, a leader in developing innovative tools for […]
Integral Molecular Out-Licenses First-in-Class Antibody Panel Targeting SLC2A4 Glucose Transporter
Philadelphia –Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce that it has out-licensed a panel of highly […]
Webinar Presented by Integral Molecular and Fierce Biotech – Best Practices for Antibody Specificity Testing for IND Submissions
Thursday, June 5, 2025 View the recording Off-target binding can be a significant hurdle in the development of antibody-based therapies, contributing to both drug […]
Integral Molecular Launches Paratope-PLUS™, a CDR-Scanning Service to Support Robust Patent Claims and Antibody Engineering
Technology aligns with new USPTO guidance for writing antibody patent claims and enables antibody engineering for novel intellectual property Philadelphia – Integral Molecular, a […]
Integral Molecular’s Out-licensed Bispecific Antibody Enters Clinical Trial for Treating Solid Tumors
Philadelphia –Integral Molecular, a leader in antibody discovery against membrane proteins, is pleased to announce that its out-licensed anti-Claudin 6 (CLDN6) bispecific antibody, CTIM-76, […]